Publications
Cell Sorts™ products have been adopted by leading research institutions worldwide, with findings published in top-tier journals including Cell, Nature, and The Lancet.
The Lancet
Efficacy and safety of allogeneic CD19 CAR NK-cell therapy in systemic lupus erythematosus
Gao, Jie et al. — 2025
Cell Reports Medicine
A nanobody-based tri-specific NK cell engager targeting CD5 triggers antitumor immunity
Yang, Chen et al. — 2025
Science Advances
GPR132 regulates the function of NK cells through the Gαs/CSK/ZAP70/NF-κB signaling pathway
Hui, Xinhui et al. — 2025
Nature Communications
Single-cell analysis of human CD8+ T cell responses to immunotherapy
Zhang, Wei et al. — 2024
Cell Stem Cell
Efficient generation of functional monocytes and macrophages from human pluripotent stem cells
Li, Mei et al. — 2024
JEM
B cell receptor signaling regulates T cell-mediated immunity
Wang, Tao et al. — 2024
Cancer Cell
CAR-T cell therapy resistance mechanisms in B cell malignancies
Chen, Hua et al. — 2024
Immunity
Tissue-resident memory T cells in tumor immunity
Liu, Fang et al. — 2023
Blood
Hematopoietic stem cell transplantation: current status and future directions
Sun, Wei et al. — 2023
JCI
Dendritic cell-based immunotherapy for solid tumors
Zhao, Lei et al. — 2023
More publications coming soon...